Target intelligence / Profile preview

Mucus (upper respiratory tract)

Molecular classification
Other (Multi-component secretion)
01

Overview

Mucus in the upper respiratory tract is a complex, viscous secretion produced primarily by goblet cells and submucosal glands lining the airways. Its primary functions include trapping inhaled pathogens and particulates, protecting the airway epithelium from environmental insults, facilitating removal via mucociliary clearance, and contributing to immune defense. The major macromolecular components are gel-forming mucins (mainly MUC5AC and MUC5B). Changes in mucus quality, such as in hyperconcentration, dehydration, or overproduction, play a key role in several airway diseases, including cystic fibrosis, chronic obstructive pulmonary disease, bronchiectasis, and asthma. Mucus itself is not a classical drug target; rather, therapies act on its physical properties or underlying regulation, not on “mucus” as a single molecule or receptor.

Other names
Respiratory mucusairway mucusphlegm (when expelled)sputum (when expectorated)tracheobronchial mucus
02

Mechanism of action

Disruption of mucin polymers to decrease viscosity - Hydration of mucus to enhance clearance - Restoration of ion transport/airway surface hydration (in CF)

03

Biological functions

Barrier protectionTrapping pathogens and particulatesHydration and lubrication of airway surfacesFacilitating mucociliary clearanceImmune response mediation/regulation
04

Disease associations

Infection (as barrier to pathogens)Inflammation (mucus hypersecretion in airway diseases)Other (Muco-obstructive lung diseases: cystic fibrosis, COPD, bronchiectasis, asthma, primary ciliary dyskinesia)
05

Safety considerations

Mucolytics may cause airway irritation or bronchospasmExcessive thinning may impair protective barrierOver-reliance in infectious contexts may worsen pathogen spread
06

Interacting drugs

Mucolytics (e.g., N-acetylcysteine, dornase alfa)

3 more in the full profile.

07

Biomarkers

Sputum mucin levels (e.g., MUC5AC, MUC5B)Mucus composition and concentrationSputum color and viscosity (clinical signs)

Beyond the preview

Go deeper on Mucus (upper respiratory tract).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mucus (upper respiratory tract).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call